Hyperpolarized 13C-labelled anhydrides as DNP precursors of metabolic MRI agents

Contrast Media and Molecular Imaging

Volumn 7, Issue 5, 2012, Pages 469-477

  Colombo Serra, Sonia ^a,b   Karlsson, Magnus ^c   Giovenzana, Giovanni Battista ^d,e   Cavallotti, Camilla ^e   Tedoldi, Fabio ^a   Aime, Silvio ^b  

^a Bracco Imaging SpA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Albeda Research   (Denmark)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^e CAGE Chemicals Srl   (Italy)

Author keywords

Dynamic nuclear polarization; Esterified electron polarizing agent; Short chain fatty acids; Symmetric anhydrides

Indexed keywords

ACID ANHYDRIDE; BUTYRIC ACID; CONTRAST MEDIUM; GADOTERIC ACID; METABOLIC ACTIVE CONTRAST AGENT; SHORT CHAIN FATTY ACID; SODIUM; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG STRUCTURE; DRUG SYNTHESIS; DYNAMIC NUCLEAR POLARIZATION; HYDROLYSIS; HYPERPOLARIZATION; POLARIZATION; PRIORITY JOURNAL;

ANHYDRIDES; CARBON ISOTOPES; CONTRAST MEDIA; FATTY ACIDS; GADOLINIUM; MAGNETIC RESONANCE IMAGING;

EID: 84864133904     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1474     Document Type: Article

References (30)

1. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001; 219(2): 316-333.
2. Carson E. Precision and accuracy considerations of physiological quantitation in PET. J Cereb Blood Flow Metab 1991; 11: A45-A50.
3. De Leon-Rodriguez LM, Lubag AJM, Malloy CR, Martinez GV, Gillies RJ, Sherry AD. Responsive MRI agents for sensing metabolism in vivo. Acc Chem Res 2009; 42(7): 948-957.
4. Terreno E, Delli Castelli D, Viale A, Aime S. Challenges for molecular MRI. Chem Rev 2010; 110(5): 3019-3042.
5. Kurhanewicz J, Vigneron DB, Brindle K, Chekmeney EY, Comment A, Cunningham CH, DeBerardinis RJ, Green GG, Leach MO, Rajan SS, Rizi RR, Ross BD, Warren WS, Malloy CR. Analysis of cancer metabolism by imaging hyperpolarized nuclei: rospects for translation to clinical research. Neoplasia 2011 13(2): 81-97.
6. Ardenkjær-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, Lerche MH, Servin R, Thaning M, Golman K. Increase in signal-to-noise ratio of >10, 000 times in liquid-state NMR. Proc Natl Acad Sci 2003; 100(18): 10158-10163.
7. 13C magnetic resonance imaging and spectroscopy. Nat Med 2007 13 (11): 1382-1387.
8. 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Res 2006; 66(22): 10855-10860.
9. The Clinical Trials Website. Available from: [13 October 2010].
10. Gallagher FA, Kettunen MI, Hu DE, Jensen PR, in't Zandt R, Karlsson M, Gisselsson A, Nelson SK, Witney TH, Bohndiek SE, Hansson G, Peitersen T, Lerche MH, Brindle KM. Production of hyperpolarized [1, 4-C-13(2)]malate from [1, 4-C-13(2)]fumarate is a marker of cell necrosis and treatment response in tumors. Proc Natl Acad Sci 2009; 106(47): 19801-19806.
11. Jensen PR, Peitersen T, Karlsson M, in't Zandt R, Gisselsson A, Hansson G, Meier S, Lerche MH. Tissue-specific short chain fatty acid metabolism and slow metabolic recovery after ischemia from hyperpolarized NMR in vivo. J Biol Chem 2009; 284(52): 36077-36082.
12. 13C ketoisocaproate. Int J Cancer 2009; 127(3): 729-736.
13. 13C]glutamate. Magn Reson Med 2011; 66(1): 18-23.
14. 13C-labelled bicarbonate. Nature 2008; 453: 940-943.
15. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005; 85: 1093-1129.
16. 13C MRI. Magn Reson Med 2008; 59: 1005-1013.
17. Schroeder MA, Cochlin LE, Heather LC, Clarke K, Radda GK, Tyler DJ. In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance. Proc Natl Acad Sci 2008; 105(33): 12051-12056.
18. Lewandowski ED, Kudej RK, White LT, O'Donnell JM, Vatner SF. Mitochondrial preference for short chain fatty acid oxidation during coronary artery constriction. Circulation 2002; 105: 367-372.
19. Ball D, Dodd M, Atherton H, Schroeder M, Carr C, Radda G, Clarke K, Tyler D. Hyperpolarized Butyrate: novel substrate for assessment of cardiac fatty acid metabolism. Proceedings of the British Chapter of ISMRM 2011; 19: 658.
20. Ardenkjaer-Larsen JH, Leach AM, Clarke N, Urbahn J, Anderson D, Skloss TW. Dynamic nuclear polarization polarizer for sterile use intent. NMR Biomed 2011; 24(8): 927-932.
21. Jannin S, Bornet A, Colombo Serra S, Bodenhausen G. Low-temperature cross polarization in view of enhancing dissolution dynamic nuclear polarization in NMR. Chem Phys Lett 2011; 517: 234-236.
22. Bunyatova EI. New investigation of organic compounds for targets with polarized hydrogen nuclei. Nucl Instrum Meth Phys Res, Sect A 1995; 356: 29-33.
23. Accardo A, Tesauro D, Aloj L, Pedone C, Morelli G. Supramolecular aggregates containing lipophilic Gd (III) complexes as contrast agents in MRI. Coord Chem Rev 2009; 253(17-18): 2193-2213.
24. 13C dynamic nuclear polarization. Phys Chem Chem Phys 2010; 12: 5804-5817.
25. Trach V, Buschmans-Denkel E, Schaper W. Relation between lipolysis and glycolysis during ischemia in the isolated rat heart. Basic Res Cardiol 1986; 81(5): 454-464.
26. Berenguer M, Zhang J, Bruce MC, Martinez L, Gonzalez T, Gurtovenko AA, Xu T, Le Marchand-Brustel Y, Govers R. Dimethyl sulfoxide enhances GLUT4 translocation through a reduction in GLUT4 endocytosis in insulin-stimulated 3T3-L1 adipocytes. Biochimie 2011; 93(4): 697-709.
27. 13C]pyruvic acid at 4.6 tesla. J Magn Reson 2009; 197: 167-175.
28. International Patent Application WO2011/124672, filed on 8 April 2011, published 13 October 2011.
29. Dhimitruka I, Velayutham M, Bobko AA, Khramtsov VV, Villamena FA, Hadad CM, Zweier JL. Large-scale synthesis of a persistent trityl radical for use in biomedical EPR applications and imaging. Bioorg Med Chem Lett 2007; 17(24): 6801-6805.
30. Xia S, Villamena FA, Hadad CM, Kuppusamy P, Li Y, Zhu H, Zweier JL. Reactivity of molecular oxygen with ethoxycarbonyl derivatives of tetrathiatriarylmethyl radicals. J Org Chem 2006; 71: 7268-7279.